Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04400409 · ClinicalTrials.gov registry record · NA
Implementation of Vascular Care Team to Improve Medical Management of PAD Patients
A NA study, sponsored by Colorado Prevention Center.
- Completed
- Registry status
- NA
- Development phase
- 166
- Enrollment target
NCT04400409: Completed NA study, sponsored by Colorado Prevention Center.
NCT04400409 is a NA study that has completed, run by Colorado Prevention Center. The registered enrollment target is 166 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04400409, a NA study, has completed, sponsored by Colorado Prevention Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 166 participants
- Enrollment target
Study Summary
This study intends to evaluate the efficacy of a multidisciplinary vascular care team utilizing an intensive guideline-based lipid reduction program in improving risk factor modification as measured by LDL-C reduction at 12 months in patients with peripheral artery disease (PAD). An additional objective is to understand the potential reach and impact if this program were extended across the University of Colorado Healthcare (UC Health) System.
Primary Outcome
Percent change from baseline to month 12 in LDL-C
Interventions
- OTHER Intervention A - Vascular Care + site 6MWT administration
- OTHER Intervention B - Standard Care + site 6MWT administration
- OTHER Intervention A - Vascular Care + CPC EQuIP 6MWT administration
- OTHER Intervention B - Standard Care + CPC EQuIP 6MWT administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2020-07-07 |
| Est. Completion | 2023-05-11 |
| Phase | NA |
What the finished NCT04400409 record still lists
NCT04400409 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 4 interventions - of which Intervention A - Vascular Care + site 6MWT administration is the first listed.
NCT04400409 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04400409 about?
NCT04400409 is a clinical study titled "Implementation of Vascular Care Team to Improve Medical Management of PAD Patients". This study intends to evaluate the efficacy of a multidisciplinary vascular care team utilizing an intensive guideline-based lipid reduction program in improving risk factor modification as measured by LDL-C reduction at 12 months in patients with peripheral artery disease (PAD). An additional objec...
What is the current status of trial NCT04400409?
This trial is currently completed. It is a NA study. The enrollment target is 166 participants. The study started on 2020-07-07. Estimated completion is 2023-05-11.
What interventions are being tested in trial NCT04400409?
The interventions under investigation include: Intervention A - Vascular Care + site 6MWT administration (OTHER), Intervention B - Standard Care + site 6MWT administration (OTHER), Intervention A - Vascular Care + CPC EQuIP 6MWT administration (OTHER), Intervention B - Standard Care + CPC EQuIP 6MWT administration (OTHER).
Who is sponsoring clinical trial NCT04400409?
This trial is sponsored by Colorado Prevention Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04400409's enrollment target sits among peer trials
166 625th of 2000 higher than 1,375 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI